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THE radiobiological characteristics of the C3H mammary tumour, rather
than conforming to rigid quantitative values which might be attributed to in-
trinsic properties ofthe carcinomaper se, have been shown to change significantly
as experimental variations in the host-tumour relationship were introduced.
Previous work demonstrated that the LD50 of 5700 r for treatment ofthe tumour
in situ in C3H mice (Cohen and Cohen, 1953a) was appreciably lowered (4500 r)
when homoplasts, originating primarily from viable fragments irradiated prior to
implantation with sublethaldoses ofrontgen rays (2000-2500r), were subsequently
treated (Cohen and Cohen, 1954b). This .increased radiosensitivity was not a
permanent change in the tumour. When the growing homoplasts, arising from
attenuated inocula, were sub-passaged to other hosts, the curability reverted to
that ofnon-attenuated tumour. It was considered likely, therefore, that a sub-
liminal resistant state had been evoked in the primary host by means of the
inoculation ofviable attenuated fragments, and that the resultant radiosensitivity
was a quantitative measure ofthis resistance.
In later experiments, the radiocurability in situ of the C3H adenocarcinoma
was determined in reciprocal F1 mice, a cross between the C3H and a low-tumour
CBA strain (Cohen and Cohen, 1954a). Here, presumably because of genetically
determined differences in histocompatibility between the tumour and the hybrid
hosts, theLD50 ofthe tumour was significantly lowerthanit hadbeenintheinbred
parent strain. It was thought that the increased radiosensitivity of the tumour
originating from radiation-attenuated implants in the C3H mice, andofthe unatte-
nuated tumour in the genetically alien F1 hybrids, was a manifestation of a prin-
ciple comnion to both situations, namely, that the tumour tissue was, to some
extent, antigenic to its host.
In the following experiments, it was decided to determine whether the com-
bination of attenuation and immunogenetic differences was additive, anta-
gonistic, or neither. It was necessary first to measure the effect ofirradiation in
vitro of the C3H carcinoma prior to implantation into F1 hybrids, and to estimate
the radiosensitivity in situ of the "takes" resulting from the foregoing procedure.
MATERIALS AND METHODS.
Animals.
The mice used in this investigation were the reciprocal F1 hybrid offspring of
matings between our C3H/Cg high mammary tumour substrain and the low-
tumour strain CBA/No, as described in a previous paper (Cohen and Cohen,RADIOBIOLOGY OF C3H MOUSE MAMMARY CARCINOMA
1954a). As before, the factor-harbouring (C3H x CBA)F1 hybrid will be desig-
nated FHC, and the reciprocal (CBA x C3H)F1 hybrid, presumably factor-free,
as FFC.
Tumnour.
AllM1 transplants were obtained from well established homoplasts growing in
C3H parent strain hosts, the preparation of the tumour for irradiation in the
plastic welled slide and its subsequent implantation by trocar being identical to
that described in the first paper of the series (Cohen and Cohen, 1953a). The
latent period after implantation varied according to the attenuation dose given,
but was apparently independent of genetic or other factors, ranging from 15 to
120 days. The average latency, at any given attenuation dose, did not differ
appreciably in either hybrid group from that previously observed in the parent
strain host. Growth rates ofthe established tumour were apparentlyindependent
of the attenuation dose and were similar to those of non-attenuated tumours in
the corresponding hosts. Tumours were treated in situ in the manner previously
described when they had reached the standard size of about 1 cm. in diameter.
Radiation Factors.
As in all previous experiments, rontgen rays generated at 240 kVp, with no
added filters, HVL 0.34 mm. Cu, FSD 25 cm., were used. The dose rate was
500r/min. for treatment in situ with the 2 cm. diameter applicator, and 600 r/min.
for attenuation in the plastic welled slide, using the 5 cm. diameter applicatorwith
full back-scatter.
EXPERIMENTAL DESIGN.
A total of 46 FHC and 57 FFC mice were used in two interdependent experi-
mnents. The first was designedtoestablish the medianlethal dose andits standard
error for the C3H carcinoma irradiated in the plastic slide immediately before
implantation into hosts from each of the two hybrid groups, for comparison with
the results obtained in the C3H parent strain hosts. Accordingly, three dose-
levels, identical to those used in the previously reported control series, were tested:
2000 r, 2500 r, and 3000 r in each genetic subgroup. In each instance, mice from
both genetic subgroups as well as C3H controls were inoculated in rotation, using
the same sample of irradiated tumour tissue. For the purpose of analysis, the
results in the C3H hosts were pooled with data for the same group obtained in pre-
vious experiments to form a large control series of 102 mice. The proportion of
"takes" in each group was tabulated (Table I), and the LD50 with its standard
error estimated after the probit method. The magnitude and significance ofany
differences between the control C3H series and the experimental hybrid groups
could be estimated on the analogy of a six-point assay.
The second experiment utilised available "takes "arising from these attenuated
inocula, 24 tumours in FHC and 32 in FFC mice, which were then treated in situ
at three dose-levels in each genetic subgroup. Since it had been previously shown
that the magnitude ofthe attenuation dose, within the range used in this investi-
gation, had little, if any effect on the subsequent response to treatment, all
"takes" were pooled, irrespective ofthe attenuation dose given, and redistributed
for the purpose ofthe second experiment among the three dose-levels to be tested
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TABLE I.--Attenuation of C3H Tumour Prior to Implantation in Hybrid Hosts.
FFC.
-A_ r
Number Number Non-
of of takes
mice. takes. (%).
9 9 0 · 28 21 25
. 20 3 85
LD50 . 2700 (±70) r
FHC.
-A-
r
Number Number Non-
of of takes
mice. takes. (%).
. 10 10 0
. 16 16 0
. 20 10 50
3000 ( 100) r
Total Hybrids Total C3H controls
Non- Non-
takes takes
Takes. (%). Takes . (%).
. 19/19 0 . 44/44 0
. 37/44 16 . 32/33 4
. 13/40 68 . 7/25 72
2800 (±+50) r . 2800 (±60) r
in situ. The proportion of cures in each group was tabulated (Table II), and the
LD50 with its standard error estimated by the probit method for each genetic
category. Using the previously reported series, in which unattenuated tumour
was irradiated in both groups of hybrid hosts, as controls, the magnitude and
significance of the attenuation effect in hybrids, both with and without the milk
factor, could be estimated using standard methods ofprobit aanlysis.
TABLE II.-Results of Treatment ofAttenuated C3H Tumour in Hybrid Hosts.
FFC.
r A
FHC.
_JA
Number Number
of mice. cured.
8 0
. 12 5
. 12 9
Cures
(%).
0
42
75
Controls.
·.
Cures. ( %).
-- 0
2/11 18
13/17 76
Number Number
of mice. cured.
8 0
. 12 1
14 6
While a significant result in this comparison would prove the existence of the
attenuation effect sought, an insignificant result would not, of course, prove that
such an effect was absent. However, an estimate of the relative radiosensitivity
of attenuated homoplasts in C3H hosts compared to controls, a ratio measuring
the attenuation effect in the parent strain, is available and its standard error is
known (Cohen and Cohen, 1954b), so that it also becomes possible to compare the
magnitude of the attenuation effect, if any, in the hybrids with that in the parent
strain (Table III).
TABLE III.-Induced Radiosensitivity with Attenuated Homoplasts in Various
Recipient Hosts.
Recipient Pre-treatment LD50 Standard error
Host. of tumour. (r). ofLDs0
Controls . 5700 . ±140
C3H
Attenuated . 4500 . 200 J
Controls . 5100 . 400
FHC
Attenuated . 4350 . 220 J
Controls . 3950 . 110
FFC
u l~ Attenuated . 3600 . 200 J
Relative acquired
Radiosensitivity.
1-27 (±-07)
1-17 (1-12)
1-08 (±'06)
Dose
(r).
2000
2500
3000
D)ose
in
situ
3000
3500
4200
Cures
(%).
0
8
43
Controls.
Cures. ( %).
0/11 0
5117 29
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RESULTS.
The results of irradiation of tumour fragments in vitro prior to implantation
in hybrid recipient hosts is shown in Table I together with the C3H control series.
From these findings the LD50 appears to be 2700 (±70) r in the FFC and 3000
(41I00) r in the FHC group. These two values do not differ significantly from
each other or from the C3H controls; the LD50 for the pooled hybrids was 2800
(±-50) r which is virtually identical with that for the C3H control series 2800
(4-60) r.
Contrary to the situation existing in the case of irradiation of the established
tumour in situ therefore the response of the C3H tumour to an "attenuation
dose" delivered before implantation is not obviously affected by genetic or extra-
chromosomal factors in the susceptible hosts inoculated. Mice in both groups in
whom attenuated inocula had not taken, exhibited no overt immunity when sub-
sequently challenged with unattenuated tumour.
Cure rates obtained when "attenuated takes" resultant from the preceding
experimient were subsequently irradiated in situ are shown in Table II together
with previously reported data on the response of non-attenuated tumours in the
corresponding hosts. On the whole, the percentage of cures in the attenuated
series seems somewhat greater than that of the controls, the difference being more
marked in the case of the FHC group. For the purpose of statistical analysis the
LI)50's and their standard errors for both attenuated and control tumours in both
hybrid groups and in the C3H parent strain are shown in Table III.
It will be noted that the relative increase in radiosensitivity induced by the
attenuation procedure is maximal in the C3H host (by a factor of 27 per cent
which is significant at p =- .0001) is smaller in the FHC host (17 per cent which is
not statistically significant) and is least in the FFC host (where the increase is
only 8 per cent and statistically insignificant). While the existence of induced
radiosensitization in the C3H mouse therefore is unequivocal and a similar but
smaller effect may possibly exist in the factor-harbouring hybrid (in which the
relatively large variation precludes conclusive analysis) the attenuation effect is
significantly smaller, possibly entirely absent, in the factor-free hybrid host.
There appears, therefore, an interesting inverse relationship in that whenever
an efficient genetically-conditioned resistance operates so as to increase the
radiosensitivity of the homoplast, little or no additional radiosensitization can be
induced by the attenuation procedure, while conversely, where genetic resistance
is less efficient; induced radiosensitization becomes more effective.
DISCUSSION.
In previous reports it had been shown that the radiosensitivity of a tumour
treated in situ varies according to the degree of resistance of the host; the LD50
being significantly lower in hybrid mice bearing the parent strain tumour than in
the C3H parent host, and lower, too, in the absence of the milk-factor than in
factor-harbouring hosts. The LD50 in the C3H mice was also significantly lowered
if the homoplast was " attenuated" by treatment with a sublethal but sufficient
(lose of radiation immediately prior to implantation. By contrast, the present
series of experiments gave essentially negative results. When tumour fragments
were irradiated before implantation, the LD50 was apparently identical in the
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parent strain host and in both hybrid subgroups, though still much smaller than
the curative dose in situ, whether in C3H or hybrid hosts. These facts suggest
that an irradiated tumour fragment is subjected at the time of implantation to
a reaction on the part ofthe host of a certain maximal intensity which cannot be
further enhanced by immunogenetic processes in the susceptible hybrid host.
When the attenuated "takes" in the two hybrid groups were subsequently
treated in situ, the degree of induced radiosensitization encountered, instead of
being large and highly significant as previously observed in the C3H host, was
smaller and statistically insignificant. This effect was also apparently less marked
in factor-free hybrids than in factor-harbouring mice. It thus appears that the
greater the immunogenetically-conditioned radiosensitivity, the less the possi-
bility of further attenuation-induced radiosensitization. It seems probable that
both the genetic resistance and the reaction to attenuated implants affect the
radiosensitivity of the homoplast through a common underlying mechanism,
probably in the nature ofthe circulating antibodies demonstrated by Gorer (1947)
and later by Fink, Snell and Kelton (1953). The combination of the two factors,
therefore, would have limited, if any, additive effects. The convergent trend
resulting from combinations of factors increasing host-resistance is shown in
Fig. 1.
The differences between the reciprocal hybrid groups reflect the action of a
maternal influence, here presumed to be identical with the milk-factor. In all
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FIG. 1.-Diagram showing the median lethal doses (scale on left) and their standard error.s-
(vertical lines) for the C3H carcinoma irradiated in various situations. Abscissae: Degrees
of genetic difference between host and tumour arbitrarily spaced so as to emphasise the
convergent trend towards lower effective dosage as increased host-resistance is evoked.
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experiments testing immunogenetic differences, the factor-free hybrid diverges
most from the C3H parent, while its factor-harbouring counterpart consistently
shows an intermediate and somewhat more variable effect. The milk-factor,
acting on the infant hybrid mouse, thus seems partially and inconstantly to obli-
terate immunogenetic differences, virtually inducing an acquired tolerance to the
tumour, analogous to the "actively acquired tolerance to foreign cells" described
by Billingham, Brent and Medawar (1953) in CBA mice.
The results of the foregoing series of experiments lend strong and consistent
support to the hypothesis that the radiosensitivity of a tumour is a function of a
specific systemic host resistance against that tumour. This single assumption
suffices to explain four observations bearing upon the problem:
(1) That the tumour growing in hybrids is more radiosensitive than in
parent-strain hosts;
(2) the milk-factor, tending to obliterate immunogenetic reactions to the
tumour, reduces its radiosensitivity;
(3) tumours arising from radiation-attenuated implants in the C3H host
are more radiosensitive (" induced radiosensitization");
(4) whole body irradiation, by deranging the resistance mechanism of the
host, reduces the radiosensitivity of the tumour (Cohen and Cohen,
1953b).
If, as seems indicated by the present investigation, an irradiated tumour fragment
is subjected at the time of implantation to a reaction on the part of the host
approaching a certain well-defined maximum limit of intensity, and mediated
through the same underlying mechanism as immunogenetic resistance, then the
following three additional observations are also seen to fit the original hypothesis:
(5)~~~~~~~~~~~g (5) The lethal dose forirradiation prior to implantation is smaller than that
required by the established tumour in situ;
(6) the lethal dose for irradiation prior to implantation is not affected by genetic or maternal factors;
(7) radiosensitization induced by prior attenuation is less marked in
hybrid hosts.
SUMMARY.
When the C3H mammary carcinoma was irradiated before implantation into reciprocal F1 hybrid hosts, the LD50 was found to be 2700 r in (CBA x C3H)F1 mice, presumably factor-free, and 3000 r in the factor-harbouring (C3H X CBA)F1 reciprocal. These values do not differ significantly from each other or from that of the same tumour in the C3H parent-strain host (2800 r). Whereas tumours arising from radiation-attenuated, viable implants in the parent strain had shown an increased radiosensitivity when subsequently treated
in 8itu, the median lethal dose for similarly attenuated tumours in F1 hybrid hosts did not differ significantly from non-attenuated homoplasts. The factor-harbour- ing hybrid, however, bore a closer resemblance to the C3H parent, showing a somewhat greater tendency to induced -radiosensitization than the factor-free
reciprocal.
It is concluded that radiosensitivity is a function ofhost resistance which may be enhanced both by inoculation ofradiation-attenuated implants, and by immu-
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nogenetic differences between the heterozygous hybrid host and the homozygous
tumour, but a combination of both procedures, which presumably act through the
same underlying mechanism, has no obvious additive effect.
We are indebted to Dr. J. F. Murray for providing facilities at the South
African Institute for Medical Research where the C3H/Cg mouse colony is main-
tained. We are also grateful to Mrs. Shelley Jacobson for invaluable skilled
assistance in the upkeep and breeding of this colony.
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